AnaSpec Introduces SensoLyte® Beta-Amyloid ELISA Kits

Fremont, CA, June 29, 2012 --(PR.com)-- AnaSpec, EGT Group is pleased to announce the release of the SensoLyte® ELISA kits for the quantification of human and mouse/rat β-Amyloid (1-40) or (1-42) peptide. Compared to similar kits in the industry, these kits are a one-step assay optimized to detect human or mouse/rat beta-Amyloid (1-40) and (1-42) peptides, respectively. Test samples can be from brain lysate, cerebrospinal fluid, plasma, serum or saliva with assay time in as short as one hour (excluding incubation times). A 96-well plate with wells pre-coated with monoclonal anti-β-Amyloid (1-40) or (1-42) specific capture antibodies and blocked with a proprietary blocking solution is included in each kit. These kits are highly sensitive, specific and reproducible. Ample materials and reagents are provided to measure 80 samples in a 96-well plate format. Dr. Patrick L. McGeer (Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada) feedbacks as kits are reliable and simple to use with reproducible results.

For more information, please visit http://www.anaspec.com/products/promotions.asp?id=101&col=1&row=1